Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Face of Anti-Aging: Liquid Facelift Demand Creates Market for Illegal Injectables—Skinspirations Urges Caution
  • USA - English


News provided by

JoTo PR

Mar 31, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX


Tampa Bay, FL (PRWEB) March 31, 2014 -- Liquid facelifts rank as the top nonsurgical cosmetic procedure in the nation, an accomplishment overshadowed as the demand for Botox and fillers has triggered a rise in illegal injectables (1), despite repeated warnings of the associated risks. Dr. Cynthia Elliott, owner of nonsurgical cosmetic facility Skinspirations, says that liquid facelifts can offer dramatic improvements in the skin, but urges potential patients to be especially cautious and seek only the help of qualified practitioners.

Rather than blindly putting trust in those who claim to be in the medical profession, it’s up to the public to be proactive about their health and do extensive research before committing to any type of procedure.

Post this

Liquid facelifts, a process during which injectable treatments such as Botox and dermal fillers—including Juvéderm, Restylane, Radiesse—are used to restore youthful facial proportions, have grown in popularity due in large part to their effectiveness, versatility and accessibility. Unlike a surgical facelift, a liquid facelift typically takes less than an hour, requires no sedation and little or no downtime, and results become apparent almost immediately. But along with the increasing demand for Botox and fillers has come a rise in illegal injectables, prompting the FDA to issue an ongoing alert for unlicensed Botox that is shipped in from other countries (1).

Dr. Elliott says that some of her clientele have been the recipients of such unauthorized products and have turned to her for corrective procedures—an unsurprising statement, as a reported 84 percent of people who suffered complications from permanent dermal fillers required corrective action (2). But some of consequences of botched procedures are impossible to repair, per Dr. Elliott:

“A client of mine had fillers in her cheeks done at another practice several years ago—she doesn’t know what substance was used, and her cheeks are so large now that her dentist had difficulty getting her to open her mouth enough for a treatment. I administered a medication that would have dissolved it if it had been a hyaluronic acid filler like Juvéderm or Restylane, but there was no response; it’s likely that the filler was permanent and, therefore, nothing can be done to remove it besides cutting it out.”

Dr. Elliott says that the number of botched cosmetic procedures is likely due to people allowing the price to dictate the quality of the surgery—a move that she says increases the chances of attracting unqualified physicians.

“An experienced practitioner should be the top consideration when seeking any cosmetic procedure, not bargain hunting,” said Dr. Elliott. “Rather than blindly putting trust in those who claim to be in the medical profession, it’s up to the public to be proactive about their health and do extensive research before committing to any type of procedure.”

Dr. Elliott says the risks associated with liquid facelifts and other cosmetic treatments can be limited by adhering to the following:

1.Check the FDA website which contains a list of approved fillers and providers. Botox and Juvéderm manufacturer Allergan also posts pictures and a list of legitimate providers on its site. Ask the practitioner if they are a legitimate provider and if they can show credentials.

2.Botox containers for the use of cosmetic alterations always contain the word “cosmetic”. Boxes and vials missing the “cosmetic” label are not approved for cosmetic use in the United States; do not allow these products to be administered. And do not be afraid to ask to see the box from the practitioner; if you are made to feel wrong for doing so, be cautious.

3.Look for practitioners with at least several years of experience & whose main focus is aesthetic treatments. The safest most effective results are going to be found by going to providers who have done thousands of Botox and injectable treatments.

Dr. Elliott, a former emergency and trauma doctor, has performed more than 14,000 non-surgical facial contouring procedures using advanced injection techniques with liquid facelift products in her Tampa Bay cosmetic facility. With a practice devoted exclusively to cosmetic and laser procedures, Dr. Elliott is sought out to perform Botox injections by the manufacturers’ representatives themselves.

For more information about Skinspirations or to schedule a free consultation, visit http://www.skinspirations.com.

About Dr. Cynthia Elliott and Skinspirations:

Cynthia Elliott, M.D., is the board-certified owner of Skinspirations, located in Clearwater, Florida. Dr. Elliott obtained her M.D. from the University of Illinois College of Medicine, and then completed her residency in Emergency Medicine at Denver General Hospital and the University of Colorado Health Sciences Center. She has been on staff at Bayfront Medical Center, St. Joseph’s Hospital, University Community Hospital and Mease Countryside Hospital, and has served on the faculty of the USF School of Medicine. Dr. Elliott currently serves as an expert witness in Cosmetic Medicine for the Florida Board of Medicine. Her company, ExpertEsthetics, provides online video training in advanced injection techniques, as well as hands-on technique training for other practitioners. Dr. Elliott is also a national and international trainer for Cutera Lasers, training other physicians in the use of aesthetic lasers with skin of all colors. Skinspirations specializes exclusively in rejuvenation, enhancement and anti-aging treatments for the face and body. With her staff of aesthetic experts, you know you’ll get the best results obtainable. Dr. Elliott has been in practice for over 20 years, and has the experience and reputation to have been chosen by the makers of Botox® Cosmetic and Juvéderm to train other physicians and practitioners in her techniques. For more information, visit http://www.skinspirations.com.

1.Callaway, Jackie. “Liquid Facelift in High Demand, Creates Market for Illegal Fillers.” Abcactionnews.com. ABC, 6 Dec. 2012. Web. 20 Mar. 2014. abcactionnews.com/news/local-news/i-team-investigates/the-demand-for-liquid-face-lifts-has-created-a-market-for-illegal-fillers.

2.“Two Out of Three Surgeons Seeing Botched Filler Ops.” Baaps.org.uk. British Association of Aesthetic Plastic Surgeons, 24 Nov. 2012. Web. 28 Apr. 2013. baaps.org.uk/about-us/press-releases/1500-two-out-of-three-surgeons-seeing-botched-filler-ops.

Karla Jo Helms, JoTo PR, +1 (888) 202-4614 Ext: 802, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.